Cargando…

Cardiotrophin-1 Deficiency Abrogates Atherosclerosis Progression

Cardiotrophin-1 (CT-1) is associated with cardiovascular (CV) diseases. We investigated the effect of CT-1 deficiency in the development and progression of atherosclerosis in double knockout Apoe(−/−)ct-1(−/−) mice. Apoe(−/−) C57Bl/6 or Apoe(−/−)ct-1(−/−) C57Bl/6 mice were fed a normal chow diet (NC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miteva, Kapka, Baptista, Daniela, Montecucco, Fabrizio, Asrih, Mohamed, Burger, Fabienne, Roth, Aline, Fraga-Silva, Rodrigo A., Stergiopulos, Nikolaos, Mach, François, Brandt, Karim J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113288/ https://www.ncbi.nlm.nih.gov/pubmed/32238841 http://dx.doi.org/10.1038/s41598-020-62596-6

Ejemplares similares

The E3 Ubiquitin Ligase Peli1 Deficiency Promotes Atherosclerosis Progression
por: Burger, Fabienne, et al.
Publicado: (2022)

NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis
por: Burger, Fabienne, et al.
Publicado: (2021)

Follicular regulatory helper T cells control the response of regulatory B cells to a high-cholesterol diet
por: Burger, Fabienne, et al.
Publicado: (2020)

Update on the Pathophysiological Activities of the Cardiac Molecule Cardiotrophin-1 in Obesity
por: Asrih, Mohamed, et al.
Publicado: (2013)

Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle Cells
por: Burger, Fabienne, et al.
Publicado: (2022)

Single-Cell Analysis Uncovers Osteoblast Factor Growth Differentiation Factor 10 as Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation Associated with Plaque Rupture in Human Carotid Artery Disease
por: Brandt, Karim J., et al.
Publicado: (2022)

Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39‐R43 of β2‐glycoprotein I
por: Moghbel, Marc, et al.
Publicado: (2022)

Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques
por: da Silva, Rafaela F., et al.
Publicado: (2020)

Atherosclerotic plaque vulnerability is increased in mouse model of lupus
por: Santiago-Raber, Marie-Laure, et al.
Publicado: (2020)

Role of Mitogen-Activated Protein Kinase Pathways in Multifactorial Adverse Cardiac Remodeling Associated with Metabolic Syndrome
por: Asrih, Mohamed, et al.
Publicado: (2013)

Role of Matrix Metalloproteinase-8 in Atherosclerosis
por: Lenglet, Sébastien, et al.
Publicado: (2013)

Role of cardiotrophin-1 in obesity and insulin resistance
por: Moreno-Aliaga, María J., et al.
Publicado: (2012)

Increased Expression of Cardiotrophin-1 in Cardiomyopathy Patients
por: Sharif, S, et al.
Publicado: (2021)

The Renin-Angiotensin System Modulates Inflammatory Processes in Atherosclerosis: Evidence from Basic Research and Clinical Studies
por: Montecucco, Fabrizio, et al.
Publicado: (2009)

Treatment with CB(2) Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice
por: Fraga-Silva, Rodrigo Araujo, et al.
Publicado: (2013)

Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis
por: Bonaventura, Aldo, et al.
Publicado: (2016)

Cardiotrophin-1 is inversely associated with obesity in non-diabetic individuals
por: Hung, Hao-Chang, et al.
Publicado: (2015)

Cardiotrophin 1 stimulates beneficial myogenic and vascular remodeling of the heart
por: Abdul-Ghani, Mohammad, et al.
Publicado: (2017)

The Expression of Adipose Tissue-Derived Cardiotrophin-1 in Humans with Obesity
por: Stephens, Jacqueline, et al.
Publicado: (2019)

Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy
por: Monserrat, Lorenzo, et al.
Publicado: (2011)

Cardiotrophin-1 plasma levels are increased in patients with diastolic heart failure
por: Celik, Atac, et al.
Publicado: (2012)

Hypertension in adult Fabry’s disease: is cardiotrophin-1 a diagnostic biomarker?
por: Marazzi, Monica Gioia, et al.
Publicado: (2014)

Update on the Role of Cannabinoid Receptors after Ischemic Stroke
por: Capettini, Luciano S. A., et al.
Publicado: (2012)

Cardiotrophin-1: a new player in energy metabolism with potential therapeutic application
por: Bustos, Matilde, et al.
Publicado: (2011)

Cardiotrophin-1 Induces Matrix Metalloproteinase-1 in Human Aortic Endothelial Cells
por: Tokito, Akinori, et al.
Publicado: (2013)

A quantitative detection of Cardiotrophin‐1 in chronic heart failure by chemiluminescence immunoassay
por: Ping, Ying, et al.
Publicado: (2021)

Immunomodulatory effects of cardiotrophin-1 on in vitro cytokine production of monocytes & CD4(+) T-lymphocytes
por: Fritzenwanger, Michael, et al.
Publicado: (2012)

Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3
por: Hogas, Simona, et al.
Publicado: (2016)

Preventive Effect of Cardiotrophin-1 Administration before DSS-Induced Ulcerative Colitis in Mice
por: Sánchez-Garrido, Ana I., et al.
Publicado: (2019)

Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population
por: Vuilleumier, Nicolas, et al.
Publicado: (2020)

Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development
por: Escoté, Xavier, et al.
Publicado: (2017)

Cardiotrophin-1 and leptin as cardiovascular risk markers in male patients with obstructive sleep apnea syndrome
por: Cakir, Isil, et al.
Publicado: (2018)

Cardiotrophin-Like Cytokine Factor 1 Exhibits a Myeloid-Biased Hematopoietic-Stimulating Function
por: Pasquin, Sarah, et al.
Publicado: (2019)

New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor
por: Montecucco, Fabrizio, et al.
Publicado: (2008)

Caveolin-1 and Atherosclerosis: Regulation of LDLs Fate in Endothelial Cells
por: Puddu, Alessandra, et al.
Publicado: (2023)

Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning
por: Iñiguez, Maria, et al.
Publicado: (2006)

Cardiotrophin-1 Induces Tumor Necrosis Factor α Synthesis in Human Peripheral Blood Mononuclear Cells
por: Fritzenwanger, Michael, et al.
Publicado: (2009)

Common Genetic Variation in the Human CTF1 Locus, Encoding Cardiotrophin-1, Determines Insulin Sensitivity
por: Lutz, Stefan Z., et al.
Publicado: (2014)

Plasma Cardiotrophin-1 as a Marker of Hypertension and Diabetes-Induced Target Organ Damage and Cardiovascular Risk
por: Gamella-Pozuelo, Luis, et al.
Publicado: (2015)

Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k12o8nhfsvj4e1653tim5tgsqd